Cormorant Asset Management’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-893,500	Closed	-$5.89M	–	115
2021 Q2	$5.89M	Sell	893,500 -606,500	-40%	-$4.18M	0.23%	79
2021 Q1	$11M	Buy	+1,500,000	New	+$12.9M	0.32%	70
2020 Q4	–	Sell	-1,000,000	Closed	-$5.94M	–	122
2020 Q3	$5.94M	Sell	1,000,000 -350,000	-26%	-$1.73M	0.26%	71
2020 Q2	$6.95M	Buy	+1,350,000	New	+$8.52M	0.3%	63
2017 Q2	–	Sell	-70,000	Closed	-$413K	–	83
2017 Q1	$413K	Sell	70,000 -38,772	-36%	-$280K	0.06%	70
2016 Q4	$587K	Hold	108,772	–	–	0.08%	69
2016 Q3	$968K	Hold	108,772	–	–	0.11%	71
2016 Q2	$1.04M	Hold	108,772	–	–	0.15%	66
2016 Q1	$1M	Hold	108,772	–	–	0.15%	70
2015 Q4	$1.37M	Sell	108,772 -50,000	-31%	-$594K	0.16%	66
2015 Q3	$1.92M	Hold	158,772	–	–	0.31%	64
2015 Q2	$2.76M	Buy	+158,772	New	+$2.86M	0.37%	54